Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gus O Nwosu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Experimental Hematology & Oncology|November 9, 2022
Targeting the integrated stress response in hematologic malignanciesGus O Nwosu, Jason A Powell, Stuart M Pitson
Cell Death & Disease|June 12, 2024
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemiaGus O Nwosu, David M Ross, Jason A Powell, et al.
Blood|April 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemiaAlexander C Lewis, Victoria S Pope, Melinda N Tea, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Experimental Hematology & Oncology|November 9, 2022
Targeting the integrated stress response in hematologic malignanciesGus O Nwosu, Jason A Powell, Stuart M Pitson
Cell Death & Disease|June 12, 2024
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemiaGus O Nwosu, David M Ross, Jason A Powell, et al.
Blood|April 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemiaAlexander C Lewis, Victoria S Pope, Melinda N Tea, et al.
Pageof 1